1. Home
  2. WAFDP vs GALT Comparison

WAFDP vs GALT Comparison

Compare WAFDP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc. Depositary Shares

WAFDP

WaFd Inc. Depositary Shares

HOLD

Current Price

$17.12

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$4.03

Market Cap

232.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFDP
GALT
Founded
N/A
2000
Country
United States
United States
Employees
2208
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
232.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WAFDP
GALT
Price
$17.12
$4.03
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
N/A
783.5K
Earning Date
N/A
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.76
52 Week High
N/A
$7.13

Technical Indicators

Market Signals
Indicator
WAFDP
GALT
Relative Strength Index (RSI) 66.27 34.21
Support Level $16.90 $3.53
Resistance Level $17.15 $7.13
Average True Range (ATR) 0.20 0.68
MACD 0.01 -0.27
Stochastic Oscillator 86.30 13.89

Price Performance

Historical Comparison
WAFDP
GALT

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: